Lanzamiento Enero 2027

Ensayo controlado aleatorizado1993Financiación no declarada

Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease

Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ

The American journal of cardiology · 44 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1993-11-01 · Am J Cardiol · vol. 72 · número 15 · págs. 1156–1162
Editorial
Elsevier BV
Citado
70 citas · más que el 82% de estudios similares · 1.6× el promedio de su campo
Referencias
34 trabajos
Acceso
De pago
Áreas de investigación
Magnesium in Health and Disease · Heart Failure Treatment and Management · Cardiac electrophysiology and arrhythmias
Palabras clave
magnesium chloride, magnesium supplementation, congestive heart failure, coronary artery disease, hypomagnesemia, ventricular arrhythmias, premature ventricular contractions, non-sustained ventricular tachycardia, serum magnesium, serum potassium, urinary magnesium excretion, plasma epinephrine, systemic vascular resistance, mean arterial pressure, sudden death
MeSH
humans, tachycardia, ventricular, coronary disease, magnesium chloride, electrolytes, administration, oral, analysis of variance, double-blind method, time factors, adult, aged, middle aged, female, male, heart failure, hemodynamics

7 autores

  • Yaver Bashir🇬🇧 · autor de correspondenciaSt George's, University of London
  • James F. Sneddon🇬🇧St George's, University of London
  • H.Anne Staunton🇬🇧St George's, University of London
  • Guy A. Haywood🇬🇧St George's, University of London
  • Iain A. Simpson🇬🇧St George's, University of London
  • William John McKenna🇬🇧St George's, University of London
  • A. John Camm🇬🇧St George's, University of London

Resumen

El texto original del estudio, en el idioma en que se publicó.

Magnesium deficiency frequently develops in patients with congestive heart failure and may increase susceptibility to lethal arrhythmias and sudden death via multiple pathophysiologic mechanisms. The effects of peroral magnesium supplementation were investigated in a randomized, double-blind, crossover trial involving 21 patients with stable congestive heart failure secondary to coronary artery disease. All were receiving long-term loop diuretics, and had normal renal function, and low or normal serum magnesium concentrations. Subjects alternately received enteric-coated magnesium chloride (15.8 mmol magnesium per day) and placebo for 6 weeks. Magnesium therapy increased serum magnesium from 0.87 +/- 0.07 to 0.92 +/- 0.05 mmol/liter (p < 0.05), serum potassium from 4.0 +/- 0.3 to 4.3 +/- 0.4 mmol/liter (p < 0.01) and urinary magnesium excretion from 2.82 +/- 0.96 to 4.74 +/- 2.38 mmol/24 hours (p = 0.001). There was no significant change in heart rate or Doppler cardiac index, but mean arterial pressure decreased from 91 +/- 10 to 87 +/- 10 mm Hg (p < 0.05) and systemic vascular resistance from 1,698 +/- 367 to 1,613 +/- 331 dynes s cm-5 (p = 0.047). The frequency of isolated ventricular premature complexes was reduced by 23% (95% confidence interval [CI] 6 to 37%; p < 0.02), couplets by 52% (95% CI 30 to 65%; p < 0.001) and nonsustained ventricular tachycardia episodes by 24% (95% CI 15 to 49%; p < 0.01). Plasma epinephrine decreased from 447 +/- 535 to 184 +/- 106 pg/ml (p = 0.02), but there was no corresponding change in plasma norepinephrine or heart rate variability.(ABSTRACT TRUNCATED AT 250 WORDS)

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.